The Independent Authority for Fiscal Responsibility (AIReF) published the study on public spending on pharmaceuticals and high-tech equipment in Extremadura on its website today, identifying areas for improvement and proposing measures to enhance spending efficiency in the region.
The study examines three items of public pharmaceutical spending: hospital pharmaceutical spending, spending on prescription medicines dispensed at pharmacies, and spending on medicines at socio-health centres. These items totalled €558m in 2022, more than a quarter of total public healthcare expenditure and accounting for 2.8% of the region’s GDP. The study also evaluates spending on investment in high-tech equipment, amounting to €4m in 2022, according to data provided by the Extremadura Health Service (SES). Accordingly, the combined total of the budget items analysed exceeds €560m.